Moderna Inc.'s shares dropped over 13% premarket after FDA's top vaccine official Peter Marks resigned under pressure from the Trump administration, highlighting the sensitive inte...
Moderna Inc.'s shares dropped over 13% premarket after FDA's top vaccine official Peter Marks resigned under pressure from the Trump administration, signaling potential regulatory ...
Moderna Inc.'s shares dropped over 13% premarket after FDA's top vaccine official Peter Marks resigned under pressure from the Trump administration, highlighting the biotech sector...
Moderna Inc.'s stock fell over 13% premarket following the resignation of FDA's top vaccine official, Peter Marks, amid reports of being forced out by the Trump administration. The...
Moderna Inc.'s shares dropped over 13% premarket after FDA's top vaccine official Peter Marks resigned under pressure from the Trump administration, highlighting significant market...
Moderna Inc.'s shares dropped over 13% in premarket trading after the resignation of FDA's top vaccine official, Peter Marks, who was reportedly forced out by the Trump administrat...
